Frontiers | Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
C-Met - Wikipedia
cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody–Drug Conjugate Targeting c-Met Overexpression Tumors | ACS Omega
Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α - ScienceDirect
c-Met Monoclonal Antibody (3D4) (37-0100)
Safety and Tolerability of c-MET Inhibitors in Cancer | SpringerLink
IJMS | Free Full-Text | HGF/c-MET Signaling in Melanocytes and Melanoma
c-Met Archives - Network of Cancer Research
c-MET
Frontiers | The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
C-Met - Wikipedia
c-Met Archives - Network of Cancer Research
About the MET Mark - Eurofins E&E North America
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer | PNAS
MET met proto-oncogene (hepatocyte growth factor receptor)
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities | Molecular Cancer | Full Text
Frontiers | HGF/c-Met Axis: The Advanced Development in Digestive System Cancer
Frontiers | Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy
c-Met as a potential therapeutic target in triple negative breast cancer - ScienceDirect
IJMS | Free Full-Text | HGF/c-MET Signaling in Melanocytes and Melanoma
C-Met - Wikipedia
Tyrosine Kinase Assay Kits | MBL Life Sience -ASIA-
Frontiers | c-Met-integrin cooperation: Mechanisms, tumorigenic effects, and therapeutic relevance
Kimono Style: The John C. Weber Collection - The Metropolitan Museum of Art
Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors | ACS Medicinal Chemistry Letters
What Is MET? - MET Crusaders
c-Met Monoclonal Antibody (3D4) (37-0100)
